Alector (ALEC) Gains from Investment Securities (2018 - 2025)
Alector (ALEC) reported Gains from Investment Securities of $11.5 million for Q4 2025, up 6.89% year-over-year from $10.7 million in Q4 2024, and up 6.89% quarter-over-quarter from $10.7 million in Q4 2024.
Alector (ALEC) Gains from Investment Securities (2018 - 2025) Analysis & Trends
Alector (ALEC) has 8 years of Gains from Investment Securities data on file, last reported at $11.5 million in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $11.5 million, up 6.89% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.5 million (up 6.89% YoY), and the FY2025 annual result was $11.5 million, up 6.89% from the prior year.
- Gains from Investment Securities grew to $11.5 million in Q4 2025 per ALEC's latest filing, from $10.7 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $13.7 million in Q4 2022 and troughed at $300750.0 in Q2 2022.
- A 5-year average of $6.0 million and a median of $6.5 million in 2021 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2021 and 2023: Gains from Investment Securities surged 9884.93% in 2021, then sank 95.82% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at $11.6 million in 2021, then increased by 17.77% to $13.7 million in 2022, then slumped by 95.82% to $572538.0 in 2023, then soared by 1773.01% to $10.7 million in 2024, then grew by 6.89% to $11.5 million in 2025.
- Business Quant data shows ALEC's Gains from Investment Securities at $11.5 million in Q4 2025, $10.7 million in Q4 2024, and $572538.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.46 Mn |
| Dec 31, 2025 | 11.46 Mn |
| Dec 31, 2024 | 10.72 Mn |
| Dec 31, 2024 | 10.72 Mn |
| Dec 31, 2023 | 572,538.00 |
| Dec 31, 2023 | 572,538.00 |
| Jun 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 13.71 Mn |
| Dec 31, 2022 | 13.71 Mn |
| Sep 30, 2022 | 7.30 Mn |
| Sep 30, 2022 | 7.30 Mn |
| Jun 30, 2022 | 300,750.00 |
| Jun 30, 2022 | 300,750.00 |
| Mar 31, 2022 | 460,926.00 |
| Mar 31, 2022 | 460,926.00 |
| Dec 31, 2021 | 11.64 Mn |
| Dec 31, 2021 | 11.64 Mn |